PDE4 inhibition is achieved by novel compounds, e.g., N-substituted diarylamine analogs. The compounds of the present invention are of Formula I: 1 wherein A, B, D, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined herein.

 
Web www.patentalert.com

< COMPOUNDS IN THE TREATMENT OF DEMENTIA RELATED DISEASES, ALZHEIMER'S DISEASE AND CONDITIONS ASSOCIATED WITH GLYCOGEN SYNTHASE KINASE-3

< AMIDE DERIVATIVES AS ION CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

> Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease

> Five-membered cyclic compounds
~ 00213